Abstract
ctDNA-based liquid biopsy reveals wider mutational profile with therapy resistance and metastasis susceptibility signatures in early-stage breast cancer patients
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have